BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2019
View Archived Issues
First patient dosed in phase II study of IMB-115
Read More
18F-Labeled PSMA ligand development leads to clinical candidate [18F]siPSMA-14
Read More
Brain axonal iron transport modulates anxiety-related behaviors
Read More
Enhancing PGK1 activity and increasing glycolysis may slow neurodegeneration in Parkinson's disease
Read More
SCO-792, a novel small-molecule enteropeptidase inhibitor blocking protein digestion in vivo
Read More
Dosing begins in NIH-funded phase II proof-of-concept study of ANS-6637
Read More
Interim data reported from BRIDGE phase III study of pegunigalsidase alpha in Fabry disease
Read More
Phase III BE VIVID study of bimekizumab in psoriasis meets all endpoints
Read More
Syros discontinues SY-1365 and focuses on the development of SY-5609
Read More
Topline results presented from first cohort of phase II study of low-dose inarigivir plus Vemlidy
Read More
First-in-human data presented for [99mTc]-ADAPT6
Read More
Bioevaluation of novel TSPO-selective PET probe, [18F]BS-224
Read More
Synthesis and characterization of novel N-carboxymethyl-substituted PSMA ligands
Read More
Medshine Discovery presents new dual SGLT1 and SGLT2 inhibitors
Read More
New FGFR inhibitors described by the Shanghai Institute of Organic Chemistry
Read More
Shanghai Meiyue Biotech Development discovers thrombin and factor XIa inhibitors
Read More
New apoptosis regulator Bcl-2 inhibitors disclosed by Jiangsu Chia Tai Tianqing Pharmaceutical Group
Read More
Shanghai Institute of Materia Medica and Jinan University patent AXL and/or FLT3 inhibitors
Read More
TAP downregulation by an aptamer-siRNA conjugate could potentiate responsiveness to immune therapy
Read More
New potent and selective ROS1/TRK family inhibitor is effective in crizotinib-resistant models
Read More
Novel albumin-binding agents for FAP-targeted radionuclide therapy presented
Read More
FDA approves Xofluza to treat influenza in those at high risk of influenza complications
Read More
Spring Bank initiates phase I study of SB-11285 alone and with nivolumab in solid tumors
Read More
SHARPIN gene variant linked to late-onset Alzheimer's disease in Japanese subjects
Read More
Scientists tie novel genetic variant in RBMX2 gene to bipolar disorder
Read More
